Skip to main content
. 2024 Sep 26;2024(9):CD006689. doi: 10.1002/14651858.CD006689.pub3

1.11. Analysis.

1.11

Comparison 1: Daily cotrimoxazole (CTXp) with any other drug regimen (mefloquine (MQ) or dihydroartemisinin‐piperaquine (DHA‐PPQ)) versus CTXp with or without placebo (current standard of care), Outcome 11: Maternal severe anaemia at delivery (< 7 g/dL)